Respiratory syncytial virus after the SARS-CoV-2 pandemic - what next?

被引：25

作者：

Mosscrop, Lucy C. ^{[1
]}

Williams, Thomas C. ^{[2
]}

Tregoning, John S. ^{[1
]}

机构：

[1] Imperial Coll London, Dept Infect Dis, London, England

[2] Univ Edinburgh, Child Life & Hlth, Edinburgh, Midlothian, Scotland

来源：

NATURE REVIEWS IMMUNOLOGY | 2022年 / 22卷 / 10期

关键词：

D O I：

10.1038/s41577-022-00764-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection. It is a large contributor to infant hospitalization and also has a substantial burden in older adults ( >= 65 years). The non-pharmaceutical interventions that were introduced to limit the spread of SARS-CoV-2 have had a marked effect on the transmission of RSV, particularly its seasonality. Here, we consider the implications of these changes to RSV transmission for future prevention strategies. The non-pharmaceutical interventions that were introduced to limit the spread of SARS-CoV-2 have also affected the transmission of respiratory syncytial virus, particularly its seasonality, with implications for the deployment of new monoclonal antibodies and vaccines.

引用

页码：589 / 590

页数：2

共 50 条

[1] Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
Lucy G. Mosscrop
Thomas C. Williams
John S. Tregoning
[J]. Nature Reviews Immunology, 2022, 22 : 589 - 590
[2] Severity and complications in infants with respiratory syncytial virus infection after the SARS-CoV-2 pandemic
Gastelum-Bernal, Melissa A.
Mondragon-Gonzalez, Luz I.
Penunuri-Ballesteros, Jhoanna M.
Felix-Ramos, Gerardo
Gomez-Jimenez, Isaac A.
Mejia, Luis R. Cadena
Frias-Mendivil, Mauricio
[J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2024, 81 (02): : 90 - 96
[3] Perturbations in Respiratory Syncytial Virus Activity During the SARS-CoV-2 Pandemic
Falsey, Ann R.
Cameron, Andrew
Branche, Angela R.
Walsh, Edward E.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 83 - 86
[4] Respiratory syncytial virus and SARS-CoV-2 coinfections in children
Halabi, Katia C.
Wang, Huanyu
Leber, Amy L.
Sanchez, Pablo J.
Ramilo, Octavio
Mejias, Asuncion
[J]. PEDIATRIC PULMONOLOGY, 2022, 57 (12) : 3158 - 3160
[5] CONCOMITANT INFECTION OF SARS-COV-2, INFLUENZA A/B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS
Bandarra, S.
Gil, F.
Neto, C.
Monteiro, L.
Brum, L.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S107 - S107
[6] SARS-CoV-2 and Respiratory Syncytial Virus Coinfection in Hospitalized Pediatric Patients
Alvares, Paula Andrade
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (04) : E164 - E166
[7] An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children
Nenna, Raffaella
Matera, Luigi
Licari, Amelia
Manti, Sara
Di Bella, Gaia
Pierangeli, Alessandra
Palamara, Anna Teresa
Nosetti, Luana
Leonardi, Salvatore
Marseglia, Gian Luigi
Midulla, Fabio
[J]. FRONTIERS IN PEDIATRICS, 2022, 10
[8] Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection
Odumade, Oludare A.
van Haren, Simon D.
Angelidou, Asimenia
[J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (SUPPL 1) : S130 - S135
[9] Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
Tripp, Ralph A.
Martin, David E.
[J]. VIRUSES-BASEL, 2022, 14 (03):
[10] Respiratory syncytial virus infection in children during SARS-CoV-2 pandemic at a referral center in Rio de Janeiro, Brazil
Lebreiro, Giuliana Pucarelli
Venceslau, Marianna Tavares
Marandino Guimaraes, Maria Angelica Arpon
Abreu, Thalita Fernandes
Rangel, Yarina
Cisne Frota, Ana Cristina
Hofer, Cristina Barroso
[J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (03)

← 1 2 3 4 5 →